Using CD203c as activation marker for MOX-allergic patients gave sensitivity = 36.4%; specificity = 94.4%; using CD63 for CIP-allergic patients gave sensitivity = 83.3%; specificity = 88.9% (Table 3). The gene discussed is CD63; the disease is hereditary sensory and autonomic neuropathy.